| Jane Grace Mercado Manalo, MD | |
|
905 Medical Park Dr, Effingham, IL 62401-2190 | |
| (217) 342-2066 | |
| (217) 342-2074 |
| Full Name | Jane Grace Mercado Manalo |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 905 Medical Park Dr, Effingham, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407813470 | NPI | - | NPPES |
| 88847357001 | Medicaid | UT |
| Mailing Address | Practice Location Address |
|---|---|
| Jane Grace Mercado Manalo, MD 905 Medical Park Dr, Effingham, IL 62401-2190 Ph: (217) 342-2066 | Jane Grace Mercado Manalo, MD 905 Medical Park Dr, Effingham, IL 62401-2190 Ph: (217) 342-2066 |
News Archive
Just in time for Christmas, and as a result of a $100,000 Houston Benefits grant from Humana Inc. earlier this year, Star of Hope Mission is unveiling a new teen room complete with a lounge area, a big screen television, Nintendo Wii, computer station, study area and a bookshelf full of games. Located in the Mission's Transitional Living Center, the "Stars of 2morrow Teen Room" will be open daily. The grant also provided for two vans to shuttle the more than 30 members of the teen program to and from numerous other activities.
A molecule previously linked to lung injuries in factory workers producing microwave popcorn might play an important role in microbial infections of the lung suffered by people with cystic fibrosis (CF), according to a recent study led by San Diego State postdoctoral researcher Katrine Whiteson.
Teenage girls and young women infected with HIV get pregnant more often and suffer pregnancy complications more frequently than their HIV-negative peers, according to new research led by Johns Hopkins investigators.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
Researchers from the University of the Basque Country have found a new Alzheimer's-related mechanism that could give rise to the development of new therapies against this disease. The study was recently published in the Cell Calcium journal, and the authors have already applied for a European patent to protect the commercial exploitation of this new discovery.
› Verified 4 days ago
Nitin Kumar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 900 W Temple Ave Ste 2500, Effingham, IL 62401 Phone: 217-540-2350 Fax: 217-347-2323 | |
Dr. Lizzette Colon-ramos, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1901 S 4th St, Ste 21, Va Effingham Cboc, Effingham, IL 62401 Phone: 217-347-7600 Fax: 217-342-9733 | |
Chariece Lasalle Robinson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 503 N Maple St, Effingham, IL 62401 Phone: 217-347-6127 Fax: 217-347-1538 | |
Dr. Rita Waleska Maldonado, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1011 Ford Ave, Effingham, IL 62401 Phone: 217-347-7600 | |
Dr. Jennifer C Maneja, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 300 N Maple St, Effingham, IL 62401 Phone: 217-342-4151 Fax: 217-347-8955 | |
Howard B Chodash, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 900 W Temple Ave Ste 2500, Effingham, IL 62401 Phone: 217-540-2350 Fax: 217-347-2323 | |
Dr. Jessica Jean Prange, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 503 N Maple St, Effingham, IL 62401 Phone: 217-342-2121 Fax: 217-347-1563 |